Moyosore Koya
Subscribe to Moyosore Koya's PostsMoyosore (Moyo) O. Koya works with healthcare clients, particularly hospitals and health systems, on a wide range regulatory and reimbursement issues. Moyo is experienced with federal Medicare and Medicare Advantage plans, including revenue recovery and complex claim reimbursement matters. Read Moyosore O. Koya's full bio.
Teleprescribing of Controlled Substances Temporarily Extended Beyond PHE
By Lisa Schmitz Mazur, Rachel Stauffer, Amanda Enyeart, Jayda Greco, Marika Miller, Grayson I. Dimick, Moyosore Koya, Marshall E. Jackson, Jr., Dale C. Van Demark and Patrick Zanayed on Jun 23, 2023
Posted In Digital Health, Employee Benefits, Health and Welfare Plans
The US Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) are extending telehealth flexibilities that allow providers to prescribe controlled substances. While the extension is in place, the DEA indicated that it will be further evaluating its recently proposed rules for post-COVID-19 public health emergency telemedicine prescription of controlled...
Continue Reading
HHS Issues Proposed Rule Under Section 1557 of the Affordable Care Act: Nondiscrimination in Health Programs and Activities
By Gregory Fosheim, Jacob Mattinson, Todd Solomon and Moyosore Koya on Aug 18, 2022
Posted In Benefit Controversies, Employee Benefits, Health and Welfare Plans
On August 4, 2022, the US Department of Health and Human Services (HHS) issued a Notice of Proposed Rulemaking (NPRM or proposed rule) to reinterpret section 1557 of the Affordable Care Act (ACA), which prohibits discrimination on the basis of race, color, national origin, sex, age or disability in a health program or activity, any...
Continue Reading
Update to Fraud Self-Disclosure Rules for Regulated Healthcare Entities
By Tony Maida, Monica Wallace and Moyosore Koya on Jan 6, 2022
Posted In Employee Benefits, Health and Welfare Plans
On November 8, 2021, the US Department of Health and Human Services (HHS) Office of Inspector General (OIG) issued an update to the Health Care Fraud Self-Disclosure Protocol (SDP). This update revises and renames the Provider Self-Disclosure Protocol last updated by OIG in 2013. The changes are mostly procedural in nature and update the SDP...
Continue Reading
